Based on the Silverback Therapeutics Inc stock forecast from 4 analysts, the average analyst target price for Silverback Therapeutics Inc is USD 30.88 over the next 12 months. Silverback Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Silverback Therapeutics Inc is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, Silverback Therapeutics Inc’s stock price was USD 14.52. Silverback Therapeutics Inc’s stock price has changed by +19.07% over the past week, -3.20% over the past month and +62.60% over the last year.
No recent analyst target price found for Silverback Therapeutics Inc
No recent average analyst rating found for Silverback Therapeutics Inc
Company Overview Silverback Therapeutics Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Silverback Therapeutics Inc (SPRY)
Loading...
Unadjusted Closing Price for Silverback Therapeutics Inc (SPRY)
Loading...
Share Trading Volume for Silverback Therapeutics Inc Shares
Loading...
Compare Performance of Silverback Therapeutics Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for SPRY
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Silverback Therapeutics Inc (Sector: Biotechnology )
Frequently Asked Questions About Silverback Therapeutics Inc (SPRY) Stock
Based on ratings from 4 analysts Silverback Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 7 buy, sell and hold ratings.
Unfortunately we do not have enough data on SPRY's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for SPRY is USD 30.88 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 27.
Unfortunately we do not have enough data on SPRY's stock to indicate if its overvalued.
The last closing price of SPRY's stock was USD 14.52.
Unfortunately we do not currently have any market capitalization data for SPRY's stock.
Based on targets from 4 analysts, the average taret price for SPRY is projected at USD 30.88 over the next 12 months.
This means that SPRY's stock price may go up by +112.64% over the next 12 months.
We can't find any ETFs which contains Silverback Therapeutics Inc's stock.
Sorry, we do not have any data on the number of employees for Silverback Therapeutics Inc.
Sorry we do not have any infomation available on Silverback Therapeutics Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Silverback Therapeutics Inc (SPRY) Stock
Based on ratings from 4 analysts Silverback Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 7 buy, sell and hold ratings.
Unfortunately we do not have enough data on SPRY's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for SPRY is USD 30.88 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 27.
Unfortunately we do not have enough data on SPRY's stock to indicate if its overvalued.
The last closing price of SPRY's stock was USD 14.52.
Unfortunately we do not currently have any market capitalization data for SPRY's stock.
Based on targets from 4 analysts, the average taret price for SPRY is projected at USD 30.88 over the next 12 months.
This means that SPRY's stock price may go up by +112.64% over the next 12 months.
We can't find any ETFs which contains Silverback Therapeutics Inc's stock.
Sorry, we do not have any data on the number of employees for Silverback Therapeutics Inc.
Sorry we do not have any infomation available on Silverback Therapeutics Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SPRY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
